Celldex Announces Pricing of $300 Million Public Offering of Common Stock
HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. ("Celldex" or the "Company") (NASDAQ:CLDX) today announced the pricing...
Neutral
0.0